164 related articles for article (PubMed ID: 21172362)
1. Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake.
Serrano A; Pavón FJ; Tovar S; Casanueva F; Señarís R; Diéguez C; de Fonseca FR
Neuropharmacology; 2011 Mar; 60(4):593-601. PubMed ID: 21172362
[TBL] [Abstract][Full Text] [Related]
2. Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus.
Brunetti L; Ferrante C; Orlando G; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Shohreh R; Manippa F; Ricciuti A; Mollica A; Vacca M
Peptides; 2013 Oct; 48():83-8. PubMed ID: 23916912
[TBL] [Abstract][Full Text] [Related]
3. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
[TBL] [Abstract][Full Text] [Related]
4. Obestatin inhibits dopamine release in rat hypothalamus.
Brunetti L; Di Nisio C; Recinella L; Orlando G; Ferrante C; Chiavaroli A; Leone S; Di Michele P; Shohreh R; Vacca M
Eur J Pharmacol; 2010 Sep; 641(2-3):142-7. PubMed ID: 20553917
[TBL] [Abstract][Full Text] [Related]
5. Role of oleoylethanolamide as a feeding regulator in goldfish.
Tinoco AB; Armirotti A; Isorna E; Delgado MJ; Piomelli D; de Pedro N
J Exp Biol; 2014 Aug; 217(Pt 15):2761-9. PubMed ID: 24855680
[TBL] [Abstract][Full Text] [Related]
6. Brain molecules and appetite: the case of oleoylethanolamide.
Sarro-Ramírez A; Sánchez-López D; Tejeda-Padrón A; Frías C; Zaldívar-Rae J; Murillo-Rodríguez E
Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):88-91. PubMed ID: 23464987
[TBL] [Abstract][Full Text] [Related]
7. Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide.
Romano A; Potes CS; Tempesta B; Cassano T; Cuomo V; Lutz T; Gaetani S
Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1266-73. PubMed ID: 24064338
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Ghrelin Levels and Hypothalamic Orexigenic AgRP and NPY Neuropeptide Expression in Models of Jejuno-Colonic Short Bowel Syndrome.
Gillard L; Billiauws L; Stan-Iuga B; Ribeiro-Parenti L; Jarry AC; Cavin JB; Cluzeaud F; Mayeur C; Thomas M; Freund JN; Lacorte JM; Le Gall M; Bado A; Joly F; Le Beyec J
Sci Rep; 2016 Jun; 6():28345. PubMed ID: 27323884
[TBL] [Abstract][Full Text] [Related]
9. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
Cani PD; Montoya ML; Neyrinck AM; Delzenne NM; Lambert DM
Br J Nutr; 2004 Nov; 92(5):757-61. PubMed ID: 15533263
[TBL] [Abstract][Full Text] [Related]
10. PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones.
Parkinson JR; Dhillo WS; Small CJ; Chaudhri OB; Bewick GA; Pritchard I; Moore S; Ghatei MA; Bloom SR
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E698-708. PubMed ID: 18285527
[TBL] [Abstract][Full Text] [Related]
11. Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation.
Soria-Gómez E; Guzmán K; Pech-Rueda O; Montes-Rodríguez CJ; Cisneros M; Prospéro-García O
Pharmacol Res; 2010 May; 61(5):379-84. PubMed ID: 20100574
[TBL] [Abstract][Full Text] [Related]
12. The gene expression of the hypothalamic feeding-regulating peptides in cisplatin-induced anorexic rats.
Yoshimura M; Matsuura T; Ohkubo J; Ohno M; Maruyama T; Ishikura T; Hashimoto H; Kakuma T; Yoshimatsu H; Terawaki K; Uezono Y; Ueta Y
Peptides; 2013 Aug; 46():13-9. PubMed ID: 23684922
[TBL] [Abstract][Full Text] [Related]
13. The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.
Umehara H; Fabbri R; Provensi G; Passani MB
Pharmacol Res; 2016 Nov; 113(Pt A):100-107. PubMed ID: 27543461
[TBL] [Abstract][Full Text] [Related]
14. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.
Provensi G; Coccurello R; Umehara H; Munari L; Giacovazzo G; Galeotti N; Nosi D; Gaetani S; Romano A; Moles A; Blandina P; Passani MB
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11527-32. PubMed ID: 25049422
[TBL] [Abstract][Full Text] [Related]
15. Role of the area postrema in the hypophagic effects of oleoylethanolamide.
Romano A; Gallelli CA; Koczwara JB; Braegger FE; Vitalone A; Falchi M; Micioni Di Bonaventura MV; Cifani C; Cassano T; Lutz TA; Gaetani S
Pharmacol Res; 2017 Aug; 122():20-34. PubMed ID: 28535974
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
17. Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion.
Vázquez MJ; González CR; Varela L; Lage R; Tovar S; Sangiao-Alvarellos S; Williams LM; Vidal-Puig A; Nogueiras R; López M; Diéguez C
Endocrinology; 2008 Sep; 149(9):4534-43. PubMed ID: 18499762
[TBL] [Abstract][Full Text] [Related]
18. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
Sihag J; Jones PJH
Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
[TBL] [Abstract][Full Text] [Related]
19. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
[TBL] [Abstract][Full Text] [Related]
20. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.
Gaetani S; Fu J; Cassano T; Dipasquale P; Romano A; Righetti L; Cianci S; Laconca L; Giannini E; Scaccianoce S; Mairesse J; Cuomo V; Piomelli D
J Neurosci; 2010 Jun; 30(24):8096-101. PubMed ID: 20554860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
